This ETF targets downgraded U.S. corporate bonds, providing diversified high yield exposure via an index-driven approach.

The third quarter begins in July, and UPS' management believes it will mark the inflection point for the turnaround.

This stock isn't known to be a market outperformer, producing a total return of 123% in the past 10 years (as of April 15).

Predictability: The high cost of medications adds an extra layer of unpredictability to planning for retirement. Avoiding the ...

America’s largest wholesale mortgage lender reported a notable insider sale amid a year of declining share prices.

In less than three weeks, the Nasdaq Composite's correction and the S&P 500's pullback were completely erased. Although ...

Explore how differing bond exposures and cost structures set these two long-term ETFs apart for income-focused portfolios.

Vertex Pharmaceuticals ( VRTX +1.27%) and Mirum Pharmaceuticals ( MIRM +2.18%) are two biotech stocks that share the same ...

Alphabet, which is expected to spend up to $185 billion this year on cloud infrastructure, is one company whose stock price ...

Explore how each ETF’s unique bond mix shapes risk and diversification for short-term investors weighing safety versus ...

And over the next 10 years, the company could pounce on several growth opportunities to deliver market-beating returns.

Tesla ( TSLA +2.96%) stock is on the decline. Since 2026, shares have lost more than 15% of their value. The company recently ...